The Government of Japan signs a basic agreement with Shionogi to provide million doses of oral COVID-19 treatment the company is now developing pending the regulatory approval. (Reuters) COVID-19 pandemic in Japan, COVID-19 drug developmentCOVID-19 pandemic link embed save